Stay informed with the latest data on measles and rubella cases worldwide with this report. Surveillance data, epidemiologic data, and laboratory reports are analyzed and updated monthly. For accurate and up-to-date information on the global status of measles and rubella, access this report. To rece

8 views • 63 slides

The clinical algorithm outlines the evaluation process for a patient presenting with a rash, focusing on the assessment for measles transmission. It covers key criteria, testing recommendations, and guidelines for suspected measles cases. Healthcare providers can utilize this algorithm to determine

0 views • 5 slides

Measles cases are on the rise in England, with a significant number reported in London. The vaccination rate is below the target set by WHO, posing a high risk of outbreaks. The campaign aims to increase awareness about the seriousness of measles, educate the public on the benefits of the MMR vaccin

0 views • 14 slides

The Global Measles and Rubella Report provides provisional data on the reported cases of measles and rubella, distributed monthly via email. Official numbers are available in July each year through the WHO/UNICEF annual data collection. The report is based on surveillance data from Member States, wi

7 views • 62 slides

Measles, mumps, and rubella are infectious diseases with serious consequences. The MMR vaccine is crucial for protection. As MMR vaccine coverage declines, there is a National MMR Call and Recall initiative in February and March 2024. General practices are advised to prepare for patient enquiries, c

3 views • 4 slides

MT DPHHS designed scenarios to help local health jurisdictions carry out disease table top exercises for the 2018-2019 grant year. The focus is on activating emergency response plans, engaging local partners, and identifying gaps in preparedness plans through a simulated measles outbreak situation i

0 views • 49 slides

Rinderpest is a viral disease characterized by high fever, lachrymal discharge, inflammation, erosions of the mouth, and diarrhea, leading to death. The disease affects cloven-hoofed animals, with cattle and water buffalo being most susceptible. Transmission occurs through aerosol vectors and ingest

0 views • 60 slides

The Democratic Republic of the Congo faced its 10th Ebola outbreak in 2018, with 608 reported cases. Measles cases in the U.S. surged between 2009-2014 due to lack of vaccination, while Acute Flaccid Myelitis causes muscle weakness. These health threats are significant and require attention to preve

3 views • 24 slides

Laboratory-based surveillance is crucial for monitoring and controlling measles outbreaks. The development of new tools like rapid diagnostic tests (RDTs) for measles diagnosis can revolutionize surveillance efforts. Challenges in introducing new diagnostics are discussed, along with the importance

0 views • 30 slides

IMNCI is an integrated approach to child health focusing on common causes of child mortality like diarrhea, pneumonia, measles, malaria, and malnutrition. Developed to address child health in developing countries, IMNCI aims to reduce under-five mortality rates through preventive and curative measur

0 views • 25 slides

This lecture covers viral infections of the respiratory system, focusing on Avian flu, Influenza Virus, Respiratory Syncytial Virus, Human metapneumovirus, Parainfluenza viruses, Measles, and Mumps virus. It includes information on the structure, symptoms, lab diagnosis, treatment, and prevention of

0 views • 11 slides

Dive into the world of measles vaccination with this detailed presentation covering vaccine composition, symptoms, protection methods, and debunking myths. Learn how vaccinations not only safeguard individuals but also contribute to herd immunity, enhancing community health.

0 views • 19 slides

The Measles and Rubella Initiative's Financial Resource Requirements for 2015-2020 were developed to support the Global Measles & Rubella Strategic Plan. The estimated budget is $2.6 billion for 2015-2020, focusing on controlling measles, rubella, and CRS in 77 countries. The costs are categorized i

0 views • 13 slides

The supply and demand dynamics of measles-containing vaccines (MCV) procured through UNICEF are explored, highlighting the total value of vaccines procured, the impact on humanitarian situations, and the challenges faced in forecasting and production. UNICEF works with multiple manufacturers for MCV

0 views • 7 slides

WHO and UNICEF have set ambitious goals for eliminating measles and rubella, emphasizing the importance of routine immunization. Progress is tracked through reported cases, vaccine coverage, and supplementary immunization activities (SIAs) in various countries of the Western Pacific Region from 2000

0 views • 20 slides

The Philippines faced surveillance challenges during the 2014 measles outbreak, including manpower capacity, logistics, data management, and reporting mechanisms. Key interventions involved activating surge capacity, conducting orientations, procuring specimen kits, and promoting efficient data coll

0 views • 18 slides

The WHO European Region has been making significant progress towards eliminating measles and rubella, with 96% reduction in measles and 97% reduction in rubella from 1990 to 2011. Strategies include ensuring high vaccination coverage and conducting supplemental immunization activities in susceptible

0 views • 24 slides

This presentation focuses on the significance of vaccine wastage in the context of measles elimination, emphasizing the factors influencing wastage, why it matters for achieving high vaccination coverage, and tools for estimating wastage. The content highlights the challenges posed by wastage on vac

0 views • 13 slides

In a measles and rubella meeting in June 2016, Dr. Craig Burgess discussed the impact of Multi-Dose Containers (MDCs) on system performance and cost trade-offs. The phases involved evaluating evidence gaps, considering factors like price per dose, health system impact, and wastage rates. The analysi

0 views • 16 slides

Measles, mumps, and rubella are infectious diseases that can be prevented with the MMR vaccine. The UK is conducting a national MMR call and recall initiative to increase vaccination coverage, especially targeting 6-11-year-olds. General practices are advised to prepare for patient inquiries, check

0 views • 4 slides

Measles cases are rising in England, particularly in London, with a concerning low vaccination rate. UKHSA predicts high risk in London and nationwide, urging for intervention to prevent further spread. A national campaign focusing on MMR vaccine uptake is set to launch on 14th July, targeting low u

0 views • 10 slides

The data presented showcases the progress and goals of measles elimination efforts in the African Region, focusing on targets for routine immunization coverage, introduction of MCV1 and MCV2 vaccines, supplementary immunization activities (SIAs), surveillance performance, and overall advancements to

0 views • 26 slides

The measles virus, also known as rubeola or morbilli virus, is a highly contagious infection that primarily affects the respiratory system. This presentation delves into the classification, characteristics, and pathogenesis of the virus, shedding light on its structure, transmission, and impact on p

0 views • 24 slides